Evidence map›Paper›PMID 39642316›Full record

ArticleJCO oncology practice2025

Oncology and Primary Care Involvement in Breast Cancer Survivorship Care More Than 5 Years After Initial Treatment.

Archana Radhakrishnan, Allison K C Furgal, Ann S Hamilton, Kevin C Ward, Christine Veenstra, Sarah T Hawley, Steven J Katz, Joy L Lee, Lauren P Wallner

Abstract read
In one paragraph

Article in JCO oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Disparities in healthcare utilization and access by measures of economic stability among female cancer survivors in Maryland.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Archana RadhakrishnanDepartment of Internal Medicine and Rogel Cancer Center, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-7689-6390
Allison K C FurgalDepartment of Biostatistics, University of Michigan, Ann Arbor, MI.
Ann S HamiltonDepartment of Population and Public Health Sciences, Keck School of Medicine, Los Angeles, CA.ORCID 0000-0001-5898-2308
Kevin C WardDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.ORCID 0000-0001-5893-6192
Christine VeenstraDepartment of Internal Medicine and Rogel Cancer Center, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-9947-7156
Sarah T HawleyDepartment of Internal Medicine and Rogel Cancer Center, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-5756-645X
Steven J KatzDepartment of Internal Medicine and Rogel Cancer Center, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-1151-861X
Joy L LeeDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA.
Lauren P WallnerDepartment of Internal Medicine and Rogel Cancer Center, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-1279-8617

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
The Challenge of Individualizing Treatments for Patients with Breast CancerP01CA163233 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAWLEY, SARAH T · 2012 to 2016
$13.4M
Engaging PCPs to optimize active surveillance of low-risk prostate cancerK08CA245237 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RADHAKRISHNAN, ARCHANA · 2019 to 2023
$1.2M
NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800003CNCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS K08 CA245237NCI NIH HHS P01 CA163233NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

purposeVery little is known about primary care involvement in the care of cancer survivors beyond the initial 5 years post-treatment when transitioning to primary care is guideline-recommended for many survivors.

methodsThe ICanCare study is a longitudinal survey of women diagnosed with breast cancer in 2014-2015 identified in the Georgia and Los Angeles SEER registries. Women were surveyed during initial treatment and again approximately 6 years later in survivorship (2021-2022; n = 1,412, 60% response rate). Respondents were asked which provider led their survivorship care (oncology, shared care, primary care provider [PCP]) and PCP management of eight common survivorship issues (range, 0-32). Multivariable-adjusted associations of participant characteristics with survivorship care delivery and PCP management of survivorship issues were evaluated using logistic and linear regression models, respectively.

resultsOver half of the women (57.2%) reported oncologist-led survivorship care delivery, 20.5% shared care, and 22.4% PCP-led. PCP management of survivorship issues was moderate (mean, 11.4, 95% CI, 11.0 to 11.8) and was highest (often/always discussed) for medication management (50.1%), improving physical activity (49.1%), and chronic disease management (43.6%). Greater confidence in PCP's ability to manage survivorship care (

conclusionIn this diverse cohort of breast cancer survivors, primary care involvement in survivorship care delivery and management of common survivorship issues remains low even more than 5 years after completing treatment and little variation was seen across survivor sociodemographic or clinical characteristics. Confidence in PCP ability to manage survivorship care was found to be important and may represent an opportunity to foster transition to primary care-led survivorship care delivery.

Indexed as

Breast NeoplasmsCancer SurvivorsMedical OncologyPrimary Health CareSurvivorshipAdultAgedFemaleHumansLongitudinal StudiesMiddle Aged

Identifiers

PMID39642316
PMCPMC12141593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.